FDA Gives Clearance for BrainScope’s Ahead 100 System

by Kathy Jones on  November 25, 2014 at 9:01 PM Medical Gadgets
RSS Email Print This Page Comment bookmark
Font : A-A+

The US Food and Drug Administration revealed that it has given a de novo clearance to Bethesda, Maryland-based company BrainScope for its Ahead 100 EEG-based system that can be used to determine which patients should be receiving a CT scan of the brain following an injury to the head.
 FDA Gives Clearance for BrainScope’s Ahead 100 System
FDA Gives Clearance for BrainScope’s Ahead 100 System

The Ahead 100 device makes use of a database of EEG readings of patients who suffered brain injuries coming through emergency rooms and used it to create markers for a template that is matched with a patient's EEG graph in order to identify signs of serious brain injury.

BrainScope revealed that it has received support from the US Department of Defense which had awarded it three contracts worth $15.93 million for further research and development of the system.

"FDA clearance of our Ahead 100 represents a major achievement in BrainScope's mission to create an objective, non-invasive, patient-friendly assessment device for rapid and easy use in emergency settings", Michael Singer, President and CEO of BrainScope, said.



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive